COEP — Coeptis Therapeutics Holdings Balance Sheet
0.000.00%
Last trade - 00:00
- $10.62m
- $11.92m
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.001 | 0.907 | 0.404 | 3.79 | 1.47 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | — | 0.008 | 3.54 |
Prepaid Expenses | |||||
Total Current Assets | 0.001 | 0.959 | 0.413 | 3.94 | 5.25 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | — | 0.071 | 0.109 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 0.172 | 76.7 | 76.2 | 7.92 | 8.07 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 0.156 | 0.005 | 0.14 | 2.17 | 2.99 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.156 | 23 | 7.19 | 3.46 | 3.76 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.016 | 53.8 | 69 | 4.45 | 4.31 |
Total Liabilities & Shareholders' Equity | 0.172 | 76.7 | 76.2 | 7.92 | 8.07 |
Total Common Shares Outstanding |